Inwards, D J <br/><br/>
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Oct 2014 
 - 2020-2024 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdu273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cladribine--administration & dosage<br/>Disease-Free Survival<br/>Drug-Related Side Effects and Adverse Reactions--pathology<br/>Female<br/>Humans<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Remission Induction<br/>Rituximab<br/>Sirolimus--administration & dosage